Top Markets
#1 MarsCoin MarsCoin +46.78%
#2 Palladium Network Palladium Network +27.95%
#3 Siren Siren +27.34%
#4 Status Status +24.27%
#5 Useless Coin Useless Coin +19.40%
#6 BankrCoin BankrCoin +15.62%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +15.16%
#8 Arweave Arweave +13.54%
#9 Ankr Network Ankr Network +13.48%
#10 Bedrock Bedrock +13.11%
Coin of the day
MarsCoin MarsCoin
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
TaiGen Biopharmaceuticals Holdings Limited TaiGen Biopharmaceuticals Holdings Limited

TaiGen Biopharmaceuticals Holdings Limited

4157
Peringkat dalam Saham #18445
TaiGen Biopharmaceuticals Holdings Limited is a global pharmaceutical firm... TaiGen Biopharmaceuticals Holdings Limited is a global pharmaceutical firm dedicated to pioneering innovative treatments for life-altering diseases. Its robust development pipeline features several key assets. Among these is Taigexyn (Nemonoxacin), a non-fluorinated quinolone antibiotic currently being advanced for the treatment of various bacterial infections, including community-acquired pneumonia and diabetic foot infections. The company is also progressing Burixafor, a stem cell mobilizer with applications in stem cell transplantation and chemosensitization. Further contributing to its portfolio is TG-1000, an antiviral medication designed to combat influenza A, B, and the avian influenza H7N9 strain. Additionally, Furaprevir, a hepatitis C virus (HCV) protease inhibitor, is under development for managing chronic hepatitis C. Established in 2001, TaiGen Biopharmaceuticals maintains its headquarters in Taipei City, Taiwan.
Harga Saham
$0.27824149
Kapitalisasi Pasar
$198.06M
Perubahan (1 hari)
-1.24%
Perubahan (1 tahun)
-11.01%
Negara
TW
Perdagangan TaiGen Biopharmaceuticals Holdings Limited (4157)

Kategori

Healthcare
Riwayat dividen untuk TaiGen Biopharmaceuticals Holdings Limited (4157)
Saham TaiGen Biopharmaceuticals Holdings Limited (simbol: 4157) telah membayar total 0 dividen.
Total semua dividen (disesuaikan dengan stock split): 0.00
Imbal hasil dividen (TTM): 0
Pembayaran dividen untuk TaiGen Biopharmaceuticals Holdings Limited (4157) dari 2026 hingga 2026
Pembayaran dividen tahunan
Tahun Dividen (disesuaikan dengan stock split) Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Daftar semua pembayaran dividen
Tahun Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Pembayaran dividen untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pembayaran dividen Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH